Hui-Ping Lin

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 4

Top Topics

Cardiovascular Disease

Cell Proliferation

Drug Administration

Endothelial Cells

Top Venues

Antioxidants (Basel, Switzerland)

Science translational medicine

British journal of pharmacology

Cardiovascular research

This page only lists publications with an associated author ORCID identifier.

Publications

Bhupesh Singla, Hui-Ping Lin, Alex Chen, WonMo Ahn, Pushpankur Ghoshal, Mary Cherian-Shaw, Joseph White, Brian K Stansfield, Gábor Csányi
Role of R-spondin 2 in arterial lymphangiogenesis and atherosclerosis. Cardiovascular research 117 (6) (2022)
Hui-Ping Lin, Bhupesh Singla, WonMo Ahn, Pushpankur Ghoshal, Maria Blahove, Mary Cherian-Shaw, Alex Chen, April Haller, David Y Hui, Kunzhe Dong, Jiliang Zhou, Joseph White, Alexis M Stranahan, Agnieszka Jasztal, Rudolf Lucas, Brian K Stansfield, David J R Fulton, Stefan Chlopicki, Gábor Csányi
Receptor-independent fluid-phase macropinocytosis promotes arterial foam cell formation and atherosclerosis. Science translational medicine 14 (663) (2022)
Bhupesh Singla, Hui-Ping Lin, WonMo Ahn, Joseph White, Gábor Csányi
Oxidatively Modified LDL Suppresses Lymphangiogenesis via CD36 Signaling. Antioxidants (Basel, Switzerland) 10 (2) (2021)
Hui-Ping Lin, Bhupesh Singla, Pushpankur Ghoshal, Jessica L Faulkner, Mary Cherian-Shaw, Paul M O'Connor, Jin-Xiong She, Eric J Belin de Chantemele, Gábor Csányi
Identification of novel macropinocytosis inhibitors using a rational screen of Food and Drug Administration-approved drugs. British journal of pharmacology 175 (18) (2018)